- Latest week
- 3 Jul 2026
- Close
- 29.580000
- Fair value
- 27.872500
- Next-week expectancy
- Undecided 50.00%
Weekly Close
Trend Line
Fair Value
Activity Lines
Up Week
Down Week
Trend Line
Volume
Close Price
Trend Line
Demand Threshold Line
Reversal Risk Level
Volume Action
Price Action
Market Dynamics
Rate of Change
0
-1.5
Top
Bottom
Raw
Close
Market Strength
30W ROC
Volume Support
Price Action Ribbon
Buy
Flip Up
Flip Down
Market Price Cycle
PC Activity Line
PC Trend Line
Weekly Close
Trend Line
Fair Value
Activity Lines
SMI
Chart Summary
Key Points
- Week Ending
- 3 Jul 2026
- Latest Close
- 29.58
- 12-Week Change
- 8.51%
- Trend Signal
- Inactive
- Next-Week Expectancy
- Undecided 50.00%
- Signal Weeks
- 0 of 4
- Vs Fair Value
- Above
- Market Dynamics
- 0.00
Over the latest 12 completed weeks ending 2026-07-03, PBLS rose 8.51%, moving from 27.26 to 29.58. The latest weekly close is above Fair Value. Trend Signal is inactive on the latest week and was active in 0 of the last 4 weeks. Market Dynamics is 0.00 on the latest week. Next-week expectancy is undecided at 50.00% based on similar historical setup states.
Industry Peers
United States equities in Biotechnology
| Stock | Exchange | Week | Open | High | Low | Close | Change |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals Inc | NASDAQ | 3 Jul 2026 | 495.83 | 529.14 | 487.62 | 528.04 | 6.50% |
| REGN Regeneron Pharmaceuticals Inc | NASDAQ | 3 Jul 2026 | 635.99 | 654.94 | 622.29 | 654.27 | 2.87% |
| ARGX argenx NV ADR | NASDAQ | 3 Jul 2026 | 896.44 | 953.58 | 890.00 | 939.68 | 4.82% |
| ALNY Alnylam Pharmaceuticals Inc | NASDAQ | 3 Jul 2026 | 296.97 | 317.17 | 291.90 | 312.78 | 5.32% |
| RVMD Revolution Medicines Inc | NASDAQ | 3 Jul 2026 | 182.26 | 193.10 | 181.50 | 189.24 | 3.83% |
| RPRX Royalty Pharma Plc | NASDAQ | 3 Jul 2026 | 56.01 | 57.80 | 55.34 | 57.77 | 3.14% |
| ONC BeiGene, Ltd. | NASDAQ | 3 Jul 2026 | 283.83 | 300.19 | 283.07 | 297.65 | 4.87% |
| BNTX BioNTech SE | NASDAQ | 3 Jul 2026 | 91.55 | 98.81 | 91.27 | 97.55 | 6.55% |
| INSM Insmed Inc | NASDAQ | 3 Jul 2026 | 105.36 | 111.92 | 103.08 | 111.60 | 5.92% |
| ROIV Roivant Sciences Ltd | NASDAQ | 3 Jul 2026 | 33.85 | 35.90 | 33.61 | 35.13 | 3.78% |
| INCY Incyte Corporation | NASDAQ | 3 Jul 2026 | 115.48 | 118.69 | 112.80 | 116.86 | 1.20% |
| MRNA Moderna Inc | NASDAQ | 3 Jul 2026 | 67.95 | 81.40 | 66.30 | 79.76 | 17.39% |
| GMAB Genmab AS | NASDAQ | 3 Jul 2026 | 26.23 | 28.78 | 25.97 | 28.52 | 8.71% |
| JAZZ Jazz Pharmaceuticals PLC | NASDAQ | 3 Jul 2026 | 231.44 | 243.81 | 230.25 | 243.47 | 5.20% |
| ASND Ascendis Pharma AS | NASDAQ | 3 Jul 2026 | 263.23 | 274.89 | 257.01 | 274.50 | 4.28% |
| BBIO BridgeBio Pharma Inc | NASDAQ | 3 Jul 2026 | 71.29 | 77.26 | 70.50 | 77.19 | 8.28% |